One of Cardiolyse product core technologies for the unique Method of ECG Evaluation to deliver personalized cardiac risk assessment has been issued with the US patent!
The patent covers the invention of the Universal ECG Score, which is designed to diagnose the cardiovascular system based on at least 148 quantitative ECG parameters rating and aggregation. The score calculated provides the diagnostic and prognostic decision on the functional cardiovascular system state and psycho-emotional state, proven to increase the accuracy and reliability of the diagnostics.
It's exciting news and we're glad the innovative proprietary algorithms developed by our preeminent scientific team are now globally recognized and protected.
More to come on our way of expanding the Cardiolyse comprehensive heart signal processing and analysis platform worldwide